Accepted at 8:04 p.m. Oct, 31, 2023 by Alex
Author: Fhl966
Related Note: 1497203185934
Rationale for change

Rituximab is also indicated for TTP per FA 32nd Ed. 2022

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Platelet_disorders #AK_Step2_v12::#FirstAid::07_Hematology::03_Platelet_Disorders::03_Idiopathic_Thrombocytopenic_Purpura_(Immune_Thrombocytopenia)::Extra #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::02_Bleeding_Disorders:_Platelet_Disorders_DDx #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::03_Platelet_Disorders #AK_Step1_v12::#Low/HighYield::1-HighYield #PANCE::HEME::coagulation_disorders #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::18_Anticancer_monoclonal_antibodies::*Rituximab::Rituximab #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Rituximab #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::06_Other_Cancer_Drugs::Extra #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::01_Quantitative_Platelet_Disorders #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Monoclonal_Antibody_Therapy::zanki_extra #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Platelet_disorders #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::04_Thrombotic_Microangiopathies #AK_Step1_v12::#Pixorize::01_Biochemistry::18_Platelet_Disorders::05_Immune_Thrombocytopenic_Purpura_(ITP) #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::17_Platelet_disorders::*Immune_Thrombocytopenic_Purpura #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::19_Rituximab